Presentation of 1-year IVAN and 2-year CATT study results

April 18th, 2012
Rockville, Md.: ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

These two multicenter randomized clinical trials, sponsored by the National Institute of Health Research in the United Kingdom and the National Eye Institute, respectively, evaluate the relative efficacy and safety of Lucentis and Avastin in the management of neovascular age-related macular degeneration (AMD).

The presentation will also live-streamed at http://prolibraries.com/arvo/registration/event. While annual meeting registration is required for the session in Fort Lauderdale, the online is event is free.

The 2012 ARVO Annual Meeting, Translational Research: Seeing the Possibilities, takes place May 6 – 10 in Fort Lauderdale, Fla. Registration information can be found at www.arvo.org/am.

Provided by Association for Research in Vision and Ophthalmology

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

Why is Venus so horrible?

Venus sucks. Seriously, it's the worst. The global temperature is as hot as an oven, the atmospheric pressure is 90 times Earth, and it rains sulfuric acid. Every part of the surface of Venus would kill you ...

The origin of the language of life

The genetic code is the universal language of life. It describes how information is encoded in the genetic material and is the same for all organisms from simple bacteria to animals to humans. However, the ...

New challenges for ocean acidification research

Over the past decade, ocean acidification has received growing recognition not only in the scientific area. Decision-makers, stakeholders, and the general public are becoming increasingly aware of "the other carbon dioxide ...